Press Releases Latest Jun 02, 2023 Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide Press Releases Year None20232022202120202019201820172016201520142013 Jan 21, 2013 FDA approves alternative storage conditions for EGRIFTA™ Jan 14, 2013 Theratechnologies Announces Intent to Voluntarily Delist from NASDAQ First page « Previous page ‹ … Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Current page 32 Displaying 311 - 312 of 312
Jun 02, 2023 Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
